Facebook
Twitter
LinkedIn
ForwardCannabinoids: Physiology, Clinical Effects, and Risks
The purpose of the program is to provide evidence-based education regarding the mechanism of action, purported and supported therapeutic effects, addictive nature, adverse effects, toxicity, and treatment of cannabinoid use as well as discussion of synthetic cannabinoids, an emerging class of illicitly used psychoactive substances.
12:00-12:10 | Understand the basic pharmacology and clinical effects of marijuana and its constituent chemicals | Dr. Michael Lynch |
12:10-12:20 | Review potential for therapeutic use as well as existing medical data | Dr. Michael Lynch |
12:20-12:30 | Explore the adverse effects of medical and recreational marijuana as well as demonstrated and potential public health impacts. | Dr. Michael Lynch |
12:30-12:40 | Discuss synthetic cannabinoid mechanism of action and clinical toxicity | Dr. Michael Lynch |
12:40 –12:50 | Review treatment options for adverse effects associated with cannabinoid use | Dr. Michael Lynch |
12:50-1:00 | Q&A | Dr. Michael Lynch |
Target Audience
RNs / SW / Health Coaches / Dieticians
Learning Objectives
- Express understanding of the basic pharmacology and clinical effects of marijuana and its constituent chemicals
- Discuss the potential for therapeutic use as well as existing medical data
- Discuss the adverse effects of medical and recreational marijuana, and the potential public health impacts of both
- Discuss synthetic cannabinoid mechanism of action and clinical toxicity
- Support treatment options for adverse effects associated with cannabinoid use
12:00-12:10 | Understand the basic pharmacology and clinical effects of marijuana and its constituent chemicals | Dr. Michael Lynch |
12:10-12:20 | Review potential for therapeutic use as well as existing medical data | Dr. Michael Lynch |
12:20-12:30 | Explore the adverse effects of medical and recreational marijuana as well as demonstrated and potential public health impacts. | Dr. Michael Lynch |
12:30-12:40 | Discuss synthetic cannabinoid mechanism of action and clinical toxicity | Dr. Michael Lynch |
12:40 –12:50 | Review treatment options for adverse effects associated with cannabinoid use | Dr. Michael Lynch |
12:50-1:00 | Q&A | Dr. Michael Lynch |
Michael Lynch, MD
Assistant Professor of Emergency Medicine, Toxicology, and Pediatrics; Medical Director of the Pittsburgh Poison Center
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CCM CEU will be provide for 1 CEU and sent from UPMC Health Plan nurse planner
SW CEU will be provided for 1 CEU from the Pitt School of Social Work
Available Credit
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.00 Attendance